Tuesday, January 03, 2017 5:35:44 PM
1. By no means am I "the monitor" here. I recall now how somewhere the sign-up rules to this system dictate that a rookie gets three "introductory" posts before being allowed the regular (free membership) daily limit of fifteen. I'm not even the monitor at home, as my wife tends to run the show (she's a little less senile than I am, at least most of the time).
2. If all factors influencing stock price can be classified into either fundamental or technical, I'd tend to view "acquisition prospects" as fundamental, so I would respectfully disagree with your comment that "the fundamentals are the same as Friday." Besides the fact there is a potential, bordering on likely, acquisition, there now is the absence of toxic debt (the conversion factor with PLY is 85% of average recent market price, and that's close enough to market price so that I wouldn't deem it to be toxic). The absence of toxic debt, even if there weren't acquisition potential, makes the stock worth much more, at least in my mind, than it was before.
3. Your range of five cents to seven cents per share as company-valuation multiplies out to a range of roughly $4.5 million to $6.3 million. You'll get a lot of enthusiastic folks here thinking that you're on the low side (even my own number is nine cents per share) based upon estimated annual sales volume. What really could impact the fundamental outlook for the stock is whatever the President-elect clues us in on as regards the rollback of federal regulations.
Best wishes for the remainder of the week!
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • NBRI • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM